Prostate Cancer PSA

The Prostate Specific Antigen known as PSA are protein formed by the prostate glands that is basically originated from the blood. A man suffering from a prostate cancer has a higher PSA levels compared to normal. Prostate specific antigen test was prepared to determine the height of PSA forming to blood. Using this test was permitted by FDA to distinguish the existence of this cancerous disease with the elderly men. Prostate cancer PSA testing was likewise accepted by FDA with those patients who have a prior history to be able to check the possible comeback of the disease.

When a man is suspected to have a higher level of PSA, it’s probably the cancer has occurred. Even though, there might be another reason for the rising of the PSA. A number of factors were taken to consideration by the doctors on taking the prostate cancer PSA test, blood samples can be typically taken throughout the prostate cancer PSA test and amount is can be measured in the laboratory. PSA was also named as the “tumor marker” or rather the “biological marker” for the reason that it was utilized for detection of the diseases and was created by body the cells.

» Read more: Prostate Cancer PSA

Related posts

New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.

“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.

» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Related posts

How to Fight Cancer & Win

Product Description
Maximize your chance of recovery from cancer – and learn how to prevent it – with this down-to-earth, practical guide that has saved and improved lives since its first publishing in 1992. This accessible book presents scientific guidelines and documented facts for the successful treatment and prevention of cancer and other health problems, and is a must-read for everyone, from those looking for a cure for cancer to those looking for a roadmap to surefire prevention… More >>

» Read more: How to Fight Cancer & Win

Related posts